Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2016, Vol. 36 Issue (7): 127-133    DOI: 10.13523/j.cb.20160717
    
The Preparation Technology of Cell Drug
WANG Dian-liang
Tissue Engineering and Regenerative Medicine Laboratory, The General Hospital of The PLA Rocket Force, Beijing 100088, China
Download: HTML   PDF(495KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

The quality of cell drug preparation is directly related to the curative efficacy of cell therapy. Due to the reason that the cells for cell therapy have biological effects, the preparation technology and application solution for cell drug are of diversity, complexity and particularity, unlike the traditional biological drugs that have a unified production standard. The preparation process of cell drugs mainly include donor screening, donor detection, collection, processing, separation and purification, storage and so on. The preparation technologies of several cell drugs including hematopoietic stem cell, mesenchymal stem cell, hepatic cell and dendritic cell are briefly introduced.



Key wordsHematopoietic stem cell      Mesenchymal stem cell      Dendritic cell      Hepatic cell      Cell drug      Preparation technology     
Received: 04 February 2016      Published: 25 July 2016
ZTFLH:  Q819  
Cite this article:

WANG Dian-liang. The Preparation Technology of Cell Drug. China Biotechnology, 2016, 36(7): 127-133.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20160717     OR     https://manu60.magtech.com.cn/biotech/Y2016/V36/I7/127

[1] Onizuka M,Matsushita H,Machida S,et al.Bacterial pneumonia-induced persistent remission of severe immune thrombocytopenia after allogeneic hematopoietic stem cell transplantation.Intern Med,2016,55(2):179-183.
[2] Sheppard D,Bredeson C,Huebsch L,et al.A plerixafor-based strategy allows adequate hematopoietic stem cell collection in poor mobilizers:results from the Canadian Special Access Program.Bone Marrow Transplant,201449(6):751-755.
[3] Veeraputhiran M,Jain T,Cronin S,et al.Successful hematopoietic stem cell collection in patients who fail initial plerixafor mobilization for autologous stem cell transplant.J Clin Apher,2014,29(6):293-298.
[4] Tassoni A,Gutteridge A,Barber A C,et al.Molecular mechanisms mediating retinal reactive gliosis following bone marrow mesenchymal stem cell transplantation.Stem Cells,2015,33(10):3006-3016.
[5] Pati S,Muthuraju S,Hadi R A,et al.Neurogenic plasticity of mesenchymal stem cell,an alluring cellular replacement for traumatic brain injury.Curr Stem Cell Res Ther,2016,11(2):149-157.
[6] Aras Y,Sabanci P A,Kabatas S,et al.The effects of adipose tissue-derived mesenchymal stem cell transplantation during the acute and subacute phases following spinal cord Injury.Turk Neurosurg,2016,26(1):127-139.
[7] Whiteley J,Bielecki R,Li M,et al.An expanded population of CD34+ cells from frozen banked umbilical cord blood demonstrate tissue repair mechanisms of mesenchymal stromal cells and circulating angiogenic cells in an ischemic hind limb model.Stem Cell Rev,2014,10(3):338-350.
[8] Badowski M,Muise A,Harris D T.Mixed effects of long-term frozen storage on cord tissue stem cells.Cytotherapy,2014,16(9):1313-1321.
[9] Rodrigues R M,Heymans A,De Boe V,et al.Toxicogenomics-based prediction of acetaminophen-induced liver injury using human hepatic cell systems.Toxicol Lett,2016,240(1):50-59.
[10] Bellwon P,Truisi G L,Bois F Y,et al.Kinetics and dynamics of cyclosporine A in three hepatic cell culture systems.Toxicol In Vitro,2015,30(1 Pt A):62-78.
[11] Wei X C,Yang D D,Han X R,et al.Bioactivity of umbilical cord blood dendritic cells and anti-leukemia effect.Int J Clin Exp Med,2015,8(10):19725-19730.
[12] Yan L,Wu M,Ba N,et al.Efficacy of dendritic cell-cytokine-induced killer immunotherapy plus intensity-modulated radiation therapy in treating elderly patients with esophageal carcinoma.Genet Mol Res,2015,14(1):898-905.

[1] WANG Yu-xuan,CHEN Ting,ZHANG Yong-liang. Research Progress on the Biological Function of MiR-148[J]. China Biotechnology, 2021, 41(7): 74-80.
[2] LI Kai-xiu,SI Wei. Progress in the Treatment of Inflammatory Bowel Diseases by Exosomes Derived from Mesenchymal Stem Cells[J]. China Biotechnology, 2021, 41(7): 66-73.
[3] XIAO Yun-xi,ZHANG Jun-he,YANG Wen-wen,CHENG Hong-wei. Research Progress of Human Diploid Cells for Vaccine Production[J]. China Biotechnology, 2021, 41(11): 74-81.
[4] ZHAO Jiu-mei,WANG Zhe,LI Xue-ying. Role of Signal Pathways and Related Factors Regulating Cartilage Formation in Bone Differentiation of Bone Marrow Mesenchymal Stem Cells[J]. China Biotechnology, 2021, 41(10): 62-72.
[5] CHEN Fei,WANG Xiao-bing,XU Zeng-hui,QIAN Qi-jun. Molecular Mechanism and Clinical Research Progress of Mesenchymal Stem Cells in the Treatment of Diabetes Mellitus[J]. China Biotechnology, 2020, 40(7): 59-69.
[6] YUAN Ya-kun,LIU Guang-yang,LIU Yong-jun,XIE Ya-fang,WU Hao. Comparison of Research and Clinical Transformation on Mesenchymal Stem Cells between China and the US[J]. China Biotechnology, 2020, 40(4): 97-107.
[7] CHEN Li-jun,QU Jing-jing,XIANG Charlie. Therapeutic Potentials, Clinical Studies, and Application Prospects of Mesenchymal Stem Cells in 2019 Novel Coronavirus (COVID-19)[J]. China Biotechnology, 2020, 40(11): 43-55.
[8] ZHU Yongzhao,TAO Jin,REN Meng-meng,XIONG Ran,HE Ya-qin,ZHOU Yu,LU Zhen-hui,DU Yong,YANG Zhi-hong. Autophagy Protects Against Apoptosis of Human Placental Mesenchymal Stem Cells of Fetal Origin Induced by Tumor Necrosis Fator-α[J]. China Biotechnology, 2019, 39(9): 62-67.
[9] Wen-wen SHI,Lei ZHANG. Current Research of Micro Mechanical Environmental Effects on Mesenchymal Stem Cells’ Differentiation[J]. China Biotechnology, 2018, 38(8): 76-83.
[10] Yan ZHENG,Huan YAO,Ke YANG. SFRP5 Inhibites Osteogenic Differentiation of Human Umbilical Cord-derived Mesenchymal Stem Cells Induced by BMP9[J]. China Biotechnology, 2018, 38(7): 7-13.
[11] YUAN Ya-hong, ZHAO Shan-shan, WANG Xiao-li, TENG Zhi-ping, LI Dong-sheng, ZENG Yi. HIV-1 Tat Protein Inhibits the Hematopoiesis Support Function of Bone Marrow Mesenchymal Stem Cells[J]. China Biotechnology, 2017, 37(6): 1-8.
[12] CAO Jun-jie, LI Ai-fang, WEI Ya-lin, LIAN Jing, TANG Min. Role of Notch Signaling Pathway in Bone Morphogenetic Protein 4-induced Osteogenic Differentiation of Marrow-derived Mesenchymal Stem Cells and Its Mechanism[J]. China Biotechnology, 2017, 37(4): 48-55.
[13] WANG Dian-liang. The Problems, Solutions and Prospects of Cell Drug[J]. China Biotechnology, 2017, 37(2): 127-132.
[14] ZHAO Zheng-de, CHEN Zhen-yin, ZHANG Hui-nan, GONG Jian-ping, XU Shao-dan, LUO Zhong-li. Effects of Self-assembling Peptide Hydrogel Scaffolds for Three-dimensional Culture on Biological Behavior and Capability of Myocardium Differentiation in Bone Marrow Mesenchymal Stem Cells[J]. China Biotechnology, 2017, 37(11): 45-51.
[15] MAO Kai-yun, FAN Yue-lei, WANG Yue, LU Jiao, CHEN Da-ming. Development Status and Trend Analysis of Mesenchymal Stem Cells Therapeutic Products[J]. China Biotechnology, 2017, 37(10): 126-135.